可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Drinitsina SV, Azizova OA, Pirizev AP, et al. Correlations between electrophysiological myocardial remodeling and parameters of free radical oxidation in patients with various forms of ischemic heart disease[J]. Ter Arkh, 2006, 78(12): 27-35.
[2] Ren AJ, Yuan X, Lin L, et al. Arrhythmogenic action of endothelin-1(1-31) through conversion to endothelin-1(1-21)[J]. Exp Biol Med, 2006, 231(6): 937-941.
[3] 张津津,姚冬芳,夏云峰. 内皮素与继发性高血压的关系[J]. 心脏杂志, 2006, 18(2):234-236.
[4] 殷召,张权宇,王跃民,等.连接蛋白43表达的变化与心律失常的关系[J]. 心脏杂志, 2008, 20(2):244-247.
[5] Chua S, Sheu JJ, Chang LT, et al. Comparison of losartan and carvedilol on attenuating inflammatory and oxidative response and preserving energy transcription factors and left ventricular function in dilated cardiomyopathy rats[J]. Int Heart J, 2008, 49(5): 605-619.
[6] Ichihara S, Yamada Y, Ichihara G, et al. Attenuation of oxidative stress and cardiac dysfunction by bisoprolol in an animal model of dilated cardiomyopathy[J]. Biochem Biophys Res Commun, 2006, 350(1):105-113.
[7] Duda M, Czarnowska E, Kurzelewski M, et al. Ischemic preconditioning prevents endothelial dysfunction, P-selectin expression, and neutrophil adhesion by preventing endothelin and O-2 generation in the post-ischemic guinea-pig heart[J]. J Physiol Pharmacol, 2006, 57(4):553-569.
[8] Duda M, Konior A, Klemenska E, et al. Preconditioning protects endothelium by preventing ET-1-induced activation of NADPH oxidase and xanthine oxidase in post-ischemic heart[J]. J Mol Cell Cardiol, 2007, 42:400-410.
[9] Ozdemir R, Parlakpinar H, Polat A, et al. Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury[J]. Toxicology, 2006, 219(1-3):142-149.
[10]Tamareille S, Achour H, Amirian J, et al. Left ventricular unloading before reperfusion reduces endothelin-1 release and calcium overload in porcine myocardial infarction[J]. J Thorac Cardiov Sug, 2008, 136(2):343-351.
[11]Tawa M, Fukumoto T, Ohkita M, et al. Role of endogenous endothelin-1 in post-ischemic cardiac dysfunction and norepinephrine overflow in rat hearts[J]. Eur J Pharmacol, 2008, 591(1-3):182-188.
[12]Isaka M, Kudo A, Imamura M, et al. Endothelin receptors, localized in sympathetic nerve terminals of the heart, modulate norepinephrine release and reperfusion arrhythmias[J]. Basic Res Cardiol, 2007, 102(2):154-162.
[13]Reisner Y, Meiry G, Zeevi-Levin N, et al. Impulse conduction and gap junctional remodeling by endothelin-1 in cultured neonatal rat ventricular myocytes[J]. J Cell Mol Med, 2009, 13(3):562-573.
[14]Tang XY, Liu Q, Dai DZ, et al. CPU0213, a novel endothelin receptor antagonist, suppresses the upregulation of matrix metalloproteinases and connexin 43 in hyperthyroid myocardium[J]. Pharmacol Rep, 2008, 60(4):524-531.
[15]Redpath CJ, Rankin AC, Kane KA, et al. Anti-adrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmia[J]. J Mol Cell Cardiol, 2006, 40(5):717-724.
[16]Udvavar AR, Chen YC, Chen YJ, et al. Endothelin-1 modulates the arrhythmogenic activity of pulmonary veins[J]. J Cardiovasc Electrophysiol, 2008, 19(3):285-292.
[17]Cabo C, Yao J, Boyden PA, et al. Heterogeneous gap junction remodeling in reentrant circuits in the epicardial border zone of the healing canine infarct[J]. Cardiovasc Res, 2006, 72(2):241-249.
[18]Papp R, Gnczi M, Kovács M, et al. Gap junctional uncoupling plays a trigger role in the antiarrhythmic effect of ischemic preconditioning[J]. Cardiovasc Res, 2007, 74(3):396-405.
[19]Ryu K, Li L, Khrestian CM, et al. Effects of sterile pericarditis on connexin 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias[J]. Am J Physiol Heart Circ Physiol, 2007, 293(2):H1231-H1241.
[20]Stahlhut M, Petersen JS, Hennan JK, et al. The antiarrhythmic peptide rotigatide (ZP123) increases connexin 43 protein expression in neonatal rat ventricular cardiomyocytes[J]. Cell Commun Adhes, 2006, 13(1-2):21-27.
[21]Knezl V, Bacova B, Kolenova L, et al. Distinct lethal arrhythmias susceptibility is associated with sex-related difference in myocardial connexin-43 expression[J]. Neuro Endocrinol Lett, 2008, 29(5):798-801.
[22]Jia G, Cheng G, Gangahar DM, et al. Involvement of connexin 43 in angiotensin Ⅱ-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway[J]. J Mol Cell Cardiol, 2008, 44(5):882-890.
[23]Fischer R, Reinehr R, Lu TP, et al. Intercellular communication via gap junctions in activated rat hepatic stellate cells[J]. Gastroenterology, 2005, 128(2):433-448.
[24]Shan D, Wang H, Su Y, et al. Kappa-opioid receptor stimulation inhibits cardiac hypertrophy induced by beta 1-adrenoceptor stimulation in the rat[J]. Eur J Pharmacol, 2007, 555(2-3):100-105.
[25]范书英,柯元南,曾玉杰,等. 不同β受体阻滞剂对大鼠心肌间隙连接结构作用的对比研究[J]. 中华心血管病杂志, 2007, 35(2):182-186.
[26]陈宝平,范芳燕,毛红娇,等. 电脱偶联延迟参与κ-阿片受体兴奋引起的心肌保护作用 [J]. 中国应用生理学杂志, 2006, 22(1): 64-69.
[27]孙新,苏慧,臧益民,等. U50488H对低氧性肺动脉高压大鼠体内一氧化氮、内皮素及血管紧张素Ⅱ水平的影响 [J]. 心脏杂志, 2007, 19(3)249-251,257.
[28]Yue P, Zhang Y, Du Z, et al. Ischemia impairs the association between connexin 43 and M3 subtype of acetylcholine muscarinic receptor (M3-mAChR) in ventricular myocytes[J]. Cell Physiol Biochem, 2006, 17(3-4): 129-136.